7 results
Summary of Diuretic Agents 
Subclass, Drug, Mechanism of Action, Effects, Clinical Applications, Pharmacokinetics, Toxicities, Interaction
CARBONIC ANHYDRASE
Agents Subclass, Drug ... Pharmacokinetics, Toxicities, Interaction ... #Diuretics #Medications ... #Pharmacology # ... summary #table #nephrology
Immunosuppression in Transplantation
Induction (I):
 - Basiliximab (Simulect)
 - Alemtuzumab (Campath)
 - Rituximab
 - Anti-Thymocyte Globulin (ATG)
Induction
Immunosuppressive #Medications ... #Pharmacology # ... Table #Drugs #Induction ... Maintenance #Management #Nephrology
Peri-operative Hyperthermia - Guidelines for Crises in Anaesthesia
If prolonged or ≥ 39 C this is a
anaphylaxis (→ 3-1) Drug ... hyperthermia crisis (late sign ... Phaeochromocytoma Neurologic ... Anesthesiology #Anesthesia ... #Checklist #Diagnosis
An Algorithm for the Management of Seizures

The management of active seizures is algorithmic, starting with a
continuous vital sign ... Pharmacologic treatment ... anti-epileptic drugs ... Management #Emergency #Neurology
Nephrolithiasis: Medications Associated with Renal Stones
 • Hypercalciuria: Furosemide, Topiramate, Vitamin D/Calcium, Glucocorticoids
 • Precipitation of
Nephrolithiasis: Medications ... Precipitation of drug ... Nephrolithiasis #Medications ... Renal #Stones #pharmacology ... differential #diagnosis #nephrology
Differential Diagnosis: New-Onset Seizure in the Elderly

STRUCTURAL:
 • Stroke/TIA, Subdural hematoma, mass
 • Traumatic Brain Injury
withdrawal • Drug ... withdrawal • Medication ... Polypharmacy - Drug ... interactions ... Seizure #Elderly #Neurology
Aimovig (Erenumab)
Mechanism: Calcitonin Gene-related Peptide Receptor Antagonist 
Indication: Preventive Treatment of Migraines:
Dosing: 70 mg SQ monthly,
Receptor Antagonist Indication ... reported this drug ... Erenumab #Migraine #Neurology ... #Pharmacology #